Pages that link to "Q51557722"
Jump to navigation
Jump to search
The following pages link to Fat distribution evaluated by computed tomography and metabolic abnormalities in patients undergoing antiretroviral therapy: preliminary results of the LIPOCO study (Q51557722):
Displaying 50 items.
- Body composition changes in protease inhibitor-naive HIV-infected patients treated with two nucleoside reverse transcriptase inhibitors (Q31055878) (← links)
- The role of HIV and monocytes/macrophages in adipose tissue biology (Q33608155) (← links)
- Lipodystrophy syndrome in HIV infection: what is it, what causes it and how can it be managed? (Q33983927) (← links)
- HIV infection. (Q34011172) (← links)
- Impact of Lipodystrophy on the prevalence and components of metabolic syndrome in HIV-infected patients (Q34024617) (← links)
- Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort study (Q34091370) (← links)
- Adverse metabolic consequences of HIV protease inhibitor therapy: the search for a central mechanism (Q34187120) (← links)
- Metabolic Complications of HIV and AIDS. (Q34207456) (← links)
- Saquinavir soft gelatin capsule: a comparative safety review (Q34248421) (← links)
- Mitochondrial toxicity and HIV therapy (Q34279271) (← links)
- Metabolic complications associated with antiretroviral therapy (Q34305866) (← links)
- Successful percutaneous dihydrotestosterone treatment of gynecomastia occurring during highly active antiretroviral therapy: four cases and a review of the literature (Q34341008) (← links)
- Clinical evaluation and management of metabolic and morphologic abnormalities associated with human immunodeficiency virus (Q34461377) (← links)
- Strategies for treating HIV-related lipodystrophy (Q34481623) (← links)
- Switch studies: a review. (Q34636824) (← links)
- Pathogenesis and treatment of human immunodeficiency virus lipodystrophy (Q34639290) (← links)
- HIV disease and advanced age: an increasing therapeutic challenge (Q34967154) (← links)
- Lipoatrophic diabetes and other related syndromes (Q35078482) (← links)
- Insulin resistance in HIV-related lipodystrophy (Q35087005) (← links)
- Antiretroviral therapies associated with lipoatrophy in HIV-infected women (Q35097650) (← links)
- Mitochondrion-mediated apoptosis in HIV-1 infection (Q35161580) (← links)
- Fat distribution in women with HIV infection (Q35194384) (← links)
- Fat distribution in men with HIV infection (Q35194387) (← links)
- The metabolic effects of lopinavir/ritonavir in HIV-negative men (Q35194394) (← links)
- The effects of low-dose growth hormone in HIV-infected men with fat accumulation: a pilot study (Q35206621) (← links)
- The study of fat redistribution and metabolic change in HIV infection (FRAM): methods, design, and sample characteristics (Q35206623) (← links)
- Contribution of metabolic and anthropometric abnormalities to cardiovascular disease risk factors (Q35206635) (← links)
- Depot-specific regulation of glucose uptake and insulin sensitivity in HIV-lipodystrophy (Q35400307) (← links)
- New and emerging agents in the management of lipodystrophy in HIV-infected patients (Q35557229) (← links)
- Metabolic complications associated with HIV protease inhibitor therapy (Q35592375) (← links)
- Regional fat deposition and cardiovascular risk in HIV infection: the FRAM study (Q35644326) (← links)
- Cardiovascular implications of HIV-associated dyslipidemic lipodystrophy (Q35739799) (← links)
- HIV-related lipodystrophy and related factors (Q35769323) (← links)
- Treatment of HIV infection in the older patient (Q35917538) (← links)
- HIV-associated adipose redistribution syndrome (HARS): definition, epidemiology and clinical impact (Q36007239) (← links)
- Adverse effects of antiretroviral therapy for HIV infection: a review of selected topics (Q36081993) (← links)
- HIV-associated lipodystrophy syndrome: A review of clinical aspects (Q36171069) (← links)
- Body fat abnormality in HIV-infected children and adolescents living in Europe: prevalence and risk factors (Q36206201) (← links)
- Antiretroviral therapy associated mastopathy (Q36233724) (← links)
- People living with HIV on ART have accurate perception of lipodystrophy signs: a cross-sectional study. (Q36249550) (← links)
- HIV/AIDS pathogenesis and treatment options focusing on the viral entry inhibitors (Q36441515) (← links)
- Toxic metabolic syndrome associated with HAART. (Q36544924) (← links)
- Increased lipoprotein remnant cholesterol levels in HIV-positive patients during antiretroviral therapy (Q36616941) (← links)
- HIV and aging: implications for patient management (Q36655162) (← links)
- Therapy insight: Body-shape changes and metabolic complications associated with HIV and highly active antiretroviral therapy (Q36914988) (← links)
- Considering metabolic issues when initiating HIV therapy (Q36947452) (← links)
- Altered relationship of plasma triglycerides to HDL cholesterol in patients with HIV/HAART-associated dyslipidemia: further evidence for a unique form of metabolic syndrome in HIV patients. (Q36951647) (← links)
- Mitochondrial oxidative phosphorylation protein levels in peripheral blood mononuclear cells correlate with levels in subcutaneous adipose tissue within samples differing by HIV and lipoatrophy status (Q37114196) (← links)
- Independent associations of insulin resistance with high whole-body intermuscular and low leg subcutaneous adipose tissue distribution in obese HIV-infected women (Q37161855) (← links)
- Fat distribution and longitudinal anthropometric changes in HIV-infected men with and without clinical evidence of lipodystrophy and HIV-uninfected controls: a substudy of the Multicenter AIDS Cohort Study (Q37203062) (← links)